Hospira Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HOSPIRA, and when can generic versions of HOSPIRA drugs launch?
HOSPIRA has five hundred and eighteen approved drugs.
There are nine US patents protecting HOSPIRA drugs. There are seven tentative approvals on HOSPIRA drugs.
There are seventy patent family members on HOSPIRA drugs in thirty-eight countries and four hundred and twenty supplementary protection certificates in sixteen countries.
Summary for Hospira
International Patents: | 70 |
US Patents: | 9 |
Tradenames: | 333 |
Ingredients: | 210 |
NDAs: | 518 |
Patent Litigation for Hospira: | See patent lawsuits for Hospira |
PTAB Cases with Hospira as petitioner: | See PTAB cases with Hospira as petitioner |
Drugs and US Patents for Hospira
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira Inc | CEFAZOLIN SODIUM | cefazolin sodium | INJECTABLE;INJECTION | 065226-002 | Apr 21, 2005 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hospira | GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | gentamicin sulfate | INJECTABLE;INJECTION | 062414-009 | Aug 15, 1983 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hospira | BUPRENORPHINE HYDROCHLORIDE | buprenorphine hydrochloride | INJECTABLE;INJECTION | 074137-001 | Jun 3, 1996 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hospira | CIMETIDINE HYDROCHLORIDE | cimetidine hydrochloride | INJECTABLE;INJECTION | 074344-001 | Jan 31, 1995 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hospira | TOBRAMYCIN SULFATE | tobramycin sulfate | INJECTABLE;INJECTION | 063080-001 | Apr 30, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Hospira
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hospira | PRECEDEX | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 021038-001 | Dec 17, 1999 | 4,910,214*PED | ⤷ Try a Trial |
Hospira | BRETYLOL | bretylium tosylate | INJECTABLE;INJECTION | 017954-001 | Approved Prior to Jan 1, 1982 | RE29618 | ⤷ Try a Trial |
Hospira | TRACRIUM PRESERVATIVE FREE | atracurium besylate | INJECTABLE;INJECTION | 018831-001 | Nov 23, 1983 | 4,179,507 | ⤷ Try a Trial |
Hospira | PRECEDEX | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 021038-002 | Mar 13, 2013 | 6,716,867*PED | ⤷ Try a Trial |
Hospira | PRECEDEX | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 021038-003 | Mar 13, 2013 | 4,910,214*PED | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for HOSPIRA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
➤ Subscribe | Injection | 100 mcg/mL | ➤ Subscribe | 2009-04-08 |
➤ Subscribe | Injection | 4 mcg/mL, 20 mL vials | ➤ Subscribe | 2015-09-30 |
➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
➤ Subscribe | Injection | 4 mcg/mL, 50 mL and 100 mL vials | ➤ Subscribe | 2013-12-26 |
International Patents for Hospira Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
European Patent Office | 4066849 | ⤷ Try a Trial |
Singapore | 191706 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2013103378 | ⤷ Try a Trial |
Peru | 20131166 | ⤷ Try a Trial |
South Africa | 201301649 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Hospira Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0925294 | 56/2007 | Austria | ⤷ Try a Trial | PRODUCT NAME: 1-OXO-2(2,6-DIOXOPIPERIDIN-3-YL)-4- AMINOISOINDOLIN, AUCH 3-(4'AMINOISOINDOLIN-1'-ON)- 1-PIPERIDIN-2,6DION GENANNT, GEGEBENENFALLS IN FORM EINES SAEUREADDITIONSSALZES; REGISTRATION NO/DATE: EU/1/07/391/001 - EU/1/07/391/004 20070614 |
0627406 | SPC/GB11/026 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: FINGOLIMOD, I.E. 2-AMINO-2-(2-(4-OCTYLPHENYL)ETHYL)PROPANE-1,3-DIOL, OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: UK EU/1/11/677/001 20110317; UK EU/1/11/677/002 20110317; UK EU/1/11/677/003 20110317; UK EU/1/11/677/004 20110317 |
0126587 | SPC/GB95/030 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: MEROPENEM OPTIONALLY IN THE FORM OF A HYDRATE AND /OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REGISTERED: IT 99/1994 19940817; UK 12619/0097 19950119; UK 12619/0098 19950119; UK 12619/0099 19950119; UK 12619/0100 19950119 |
2603514 | CA 2019 00015 | Denmark | ⤷ Try a Trial | PRODUCT NAME: EN KOMBINATION AF VABORBACTAM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, OG MEROPENEM, OG/ELLER ET SALT OG/ELLER HYDRAT DERAF, SAERLIGT MEROPENEM TRIHYDRAT; REG. NO/DATE: EU/1/18/1334 20181122 |
1189916 | 1190003-2.L | Sweden | ⤷ Try a Trial | PRODUCT NAME: REGADENOSON OCH SALTER DAERAV; REG. NO/DATE: EU/1/10/643/001 20100906 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.